Aptevo BioTherapeutics
Manufacturing · Illinois, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
Medexus Pharma Inc., Chicago, Illinois, ...Website
www.ixinity.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Aptevo BioTherapeutics
Aptevo Therapeutics offers IXINITY®, a recombinant factor IX treatment specifically designed for individuals with hemophilia B. This medication is intended for both adolescent and adult patients, providing on-demand treatment and prophylaxis to manage bleeding episodes. The company also supports patients through various programs, including savings opportunities and connections with healthcare professionals. Aptevo Therapeutics aims to cater to the needs of those diagnosed with hemophilia B by ensuring access to vital treatment and resources.Explore more
Aptevo BioTherapeutics Org Chart
SC
Hemophilia Southwest Region Territory Manager
Get the full picture
Sign in to uncover key details.
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Aptevo BioTherapeutics your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at Aptevo BioTherapeutics
Click to see if Aptevo BioTherapeutics had a recent Job posting/layoffs
Aptevo BioTherapeutics, which may be a good buyer, showed buying intent in Masked Content Topic
Earning: See what the market has to say on Aptevo BioTherapeutics recently announced quarterly report
Funding: Get notified immidiatlly once Aptevo BioTherapeutics has new funding data
Product Launch: Get notified when Aptevo BioTherapeutics launches new products
Check out if Aptevo BioTherapeutics is spiking on competitors!
Check if Aptevo BioTherapeutics has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Aptevo BioTherapeutics
Compare insights from companies similar to Aptevo BioTherapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Aptevo BioTherapeutics
<$5M
1-10
Private
-
-
BR
Becca RobbinsHemophilia Midwest Region Territory Manager
Company Profile Activity
Activity Insights
Aptevo BioTherapeutics is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Aptevo BioTherapeutics is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Aptevo BioTherapeutics.
Aptevo BioTherapeutics Tech Stack
A closer look at the technologies used by Aptevo BioTherapeutics
Aptevo BioTherapeutics News & Media
Aptevo Therapeutics Reports IXINITY® and Pipeline Progress
Reports 73% Increase in IXINITY Year-Over-Year Quarterly Net Revenue in Q1 2019
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Aptevo BioTherapeutics
Sign Up For FreeTo access detailed company insights
Aptevo Therapeutics offers IXINITY®, a recombinant factor IX treatment specifically designed for individuals with hemophilia B. This medication is intended for both adolescent and adult patients, providing on-demand treatment and prophylaxis to manage bleeding episodes. The company also supports patients through various programs, including savings... Read More
